PFE : Summary for Pfizer, Inc. Common Stock - Yahoo Finance

U.S. Markets closed

Pfizer Inc. (PFE)


NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
31.59-0.04 (-0.13%)
At close: 4:02 PM EST

31.59 0.00 (0.00%)
After hours: 7:42 PM EST

People also watch:
MRKJNJJPMGEINTC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close31.63
Open31.74
Bid31.52 x 1000
Ask31.80 x 1000
Day's Range31.39 - 31.77
52 Week Range28.25 - 37.39
Volume18,753,009
Avg. Volume24,689,669
Market Cap191.7B
Beta0.96
PE Ratio (TTM)31.72
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.20 (3.79%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Can't buy love? Drug price hikes put sex beyond reach
    Associated Press3 hours ago

    Can't buy love? Drug price hikes put sex beyond reach

    Imagine not being able to afford one of life's great pleasures — sex. That's true for many older couples, doctors say. Soaring prices for prescription medicines for impotence and other problems have put ...

  • Bloomberg7 hours ago

    Sanofi to Explore Counterbid for Actelion Amid J&J Talks

    Sanofi is considering a counterbid for Actelion Ltd., potentially challenging a move by U.S. health-care giant Johnson & Johnson to acquire the Swiss biotechnology firm, people familiar with the matter ...

  • Forbes12 hours ago

    A New Antibody For Treating Acute Lymphocytic Leukemia?

    Of all the drugs being discussed at this year’s meeting of the American Society of Hematology, one caught my attention. The new agent, a monoclonal antibody to CD22 with a toxin attached, is manufactured by Pfizer. It’s called inotuzumab ozogamicin. As that’s a mouthful, some doctors call it Ino. Last summer